ArticleMacromolecular bioscience2026
Identification of Novel Growth Factor Conjugated Nanofibers for Stimulation of Neuronal Growth.
Article in Macromolecular bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Novel Growth Factor Conjugated Nanofibers for Stimulation of Neuronal Growth.Macromolecular bioscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Growth factors (GF) fulfil essential functions during organ development and regeneration. In tissue regeneration, evidence suggests that the combined application of several GFs is more efficient compared to their individual application. Single or multiple GFs are often applied to animal models of organ regeneration through release by hydrogels. Such hydrogels are often formed by self-assembling peptides (SAPs) spontaneously polymerizing into peptide nanofiber (PNF) networks. In this study, we established PNFs by conjugating an SAP backbone (KIKIQIN) with bioactive peptide sequences derived from two GFs, FGF2 and IGF1. This resulted in the GF-mimicking fusion peptides FGF2-SAP and IGF1-SAP, respectively. In these PNFs, both GFs were stably incorporated rather than released as in the case of PNF-derived hydrogels. When individually added to culture medium, FGF1-SAP and IGF1-SAP stimulated the growth of mouse primary hippocampal neurons. Notably, their growth-stimulating potential exceeded neuronal growth achieved with the SAP backbone or the GF peptides alone. Finally, combinations of FGF2-SAP, IGF1-SAP, and the SAP backbone were tested, which formed FGF2 and IGF1 presenting PNFs. Indeed, specific GF-SAP combinations resulted in elevated numbers of surviving neurons compared to individual application. In summary, in this study, we identified novel GF-SAP hybrid nanofibers capable of stimulating cellular growth. Such nanofibers, enabling stable and simultaneous presentation of multiple GFs, might be well suited for tissue regeneration in vivo.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.